Skip to main content

Halozyme Therapeutic (NQ: HALO )

50.66 -3.47 (-6.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2024 Add to My Watchlist

Other Filings

Form 144
Source: SEC/Edgar
September 08, 2004
Form 8-K
Source: SEC/Edgar
August 19, 2004
Form 424B3
Source: SEC/Edgar
August 17, 2004
Form 8-K
Source: SEC/Edgar
August 16, 2004
Form 10QSB
Source: SEC/Edgar
August 15, 2004
Form 8-K
Source: SEC/Edgar
August 15, 2004
Form SB-2/A
Source: SEC/Edgar
July 22, 2004
Form SB-2/A
Source: SEC/Edgar
June 20, 2004
Form S-8
Source: SEC/Edgar
June 09, 2004
Form 144
Source: SEC/Edgar
June 06, 2004
Form 10KSB/A
Source: SEC/Edgar
May 26, 2004
Form SC TO-I/A
Source: SEC/Edgar
May 26, 2004
Form 8-K
Source: SEC/Edgar
May 23, 2004
Form 144
Source: SEC/Edgar
May 20, 2004
Form 144
Source: SEC/Edgar
May 19, 2004
Form 8-K/A
Source: SEC/Edgar
May 19, 2004
Form 144
Source: SEC/Edgar
May 17, 2004
Form NT 10-Q
Source: SEC/Edgar
May 16, 2004
Form 10QSB
Source: SEC/Edgar
May 16, 2004
Form 10QSB
Source: SEC/Edgar
May 13, 2004
Form SC 13D
Source: SEC/Edgar
May 05, 2004
Form 424B3
Source: SEC/Edgar
April 29, 2004
Form S-2/A
Source: SEC/Edgar
April 25, 2004
Form 144
Source: SEC/Edgar
April 22, 2004
Form SB-2
Source: SEC/Edgar
April 22, 2004
Form 144
Source: SEC/Edgar
April 21, 2004
Form 144
Source: SEC/Edgar
April 19, 2004
Form S-2
Source: SEC/Edgar
April 07, 2004
Form 8-K
Source: SEC/Edgar
April 05, 2004
Form SC 13G/A
Source: SEC/Edgar
April 04, 2004
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.